Advertisement
Advertisement
U.S. markets close in 21 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Palatin Technologies, Inc. (PTN)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
6.00+0.08 (+1.38%)
As of 02:48PM EDT. Market open.
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • A
    Adam
    Just sit back and be patient.
    Wait until the trial results for dry eye disease. If they are good and it passes the trial, this company will have 2 drugs that are FDA approved.

    This company will get bought out by a big pharmaceutical company for the $1-2 billion region. In which case that’s where the $50-$100 price targets come from.

    Don’t look at day to day fluctuations. Just wait for the phase 3 trial results for dry eye disease.
    If it’s a green light, this company is gold, 1000% gain.

    Wait and see, when the results draw closer, the short positions will all be closed. Price will rocket ship.
    Bullish
  • J
    Jonnie
    Offering is now imminent.
  • J
    Jonnie
    $5 coming soon.
  • m
    mark centracchio
    Wow PTN missed its estimate by a ton. Great. There goes the stock price. Get out now
  • M
    Meng
    Now it's over $0.30 pre RS level. If it goes over $0.50, it will reach $1.00 easily
  • k
    kevin
    estimates were bull! they are finally increasing sales of vylessi dramatically and if sales continue will be break even by end of year. it has taken too long to do this but now it's done they are attractive to buyers! would love to see big pharma come in and buyout company entirely
  • J
    Joe
    Great volume already today in anticipation of 4Q results. PTN has 3 big things going for it. They alluded to greater revenue for Vyleesi, their phase 2 ulcerative colitis trial, and phase 3 dry eye trial both concluding in early 2023. This is in a great position to take off!
  • N
    NK
    can’t understand why a company with sp arnd $7 to be evaluated @ $70…
  • C
    Chris
    Took my 80% loss on this.
  • M
    Meng
    needs to go well above $10.5 and then the private placement people are willing to convert their $13 million into common shares.
  • m
    mark centracchio
    Something with earnings happening today? Is it just an announcement of how good the report should be in two weeks or is it the actual earnings report??
  • k
    kevin
    It doesn't take alot of buying for this to skyrocket as float is so low after RS.
  • m
    mark centracchio
    HC Wainwright initiates $70 price target
  • A
    Adam
    It’s time for people to buy back their shorts.
    I feel bad for those who were downplaying this company and manipulating the price with shorts.
    Very soon it’s time to fly 🚀
    Bullish
  • J
    Joe
    Still 30M in cash!
  • j
    josephn
    Keep the new numbers in perspective. Yesterday's "big" jump pre split would have been 5.5 cents bring the stock to a whopping 25 cents.
  • m
    mark centracchio
    Is this stock being shorted daily?? Dnt understand the stock being up in morning and sudden dip. It’s a daily thing
  • J
    Jonnie
    This is jumping on this news “topline data anticipated in the second quarter of calendar year 2023”?? I’m sure there’s gonna be an offering before that.
  • J
    John
    People I'm well invested in this company. However, can any body tell me why finally there is such movement upwards?? I love to see this, however, I like to know understand why finally the push up!!
  • E
    Eric
    Just get to $20 please.
Advertisement
Advertisement